State-of-the-art DNA testing and the latest pharmacogenomic evidence to support your prescribing decisions: fewer adverse reactions, more personalised prescribing and a new service line for your practice.
Offer your patients the most advanced prescribing support in your specialty: Clopidogrel and cardiovascular medicines, mental health medicines and more.
Every Mantara report follows guidance from leading pharmacogenomic experts across the UK and Europe, using the same protocol and recommendations as the UPGx study published in The Lancet (2023).
World-class DNA testing
Partner laboratory in Germany with validated, high-precision genotyping.
High-quality reporting
CE and UKCA-marked software from bio.logis, accredited by the College of American Pathologists.
Only actionable advice
DPWG recommendations and PREPARE findings. No “informational” results.
The PREPARE-UPGx trial in numbers
Published in The Lancet, 2023. Led by European experts including the NHS Chair of Pharmacogenetics at the University of Liverpool.
6,930
patients across 7 European countries, including the UK
30%
fewer serious side effects with genotype-guided prescribing
12
genes in the panel we follow
78
medicines with DPWG-actionable advice
PARTNER WITH MANTARA
A model that works for your practice
Stock kits at consumable cost and only pay for laboratory analysis when a sample is registered.
STOCK KITS
£25 per kit, upfront
Covers consumables and tracked postage. Keep kits on the shelf for patients who want to test today.
Barcoded kits added to your stock
Automatic reorder when you run low
PAY AS YOU TEST
Lab fee on registration
The laboratory analysis is invoiced monthly, only for samples your patients register.
One automatic PDF invoice a month
Remaining £274 only payable on registration
PARTNER PORTAL
Every patient, one dashboard
See which kits are with patients, at the lab or reported, and share reports securely.
Track status in real time
Order kits in bulk
GETTING STARTED
Live in a week
01
DAY 1
Book a 10-minute call
We learn about your practice and patients.
02
DAY 2
Verify and set up
GMC, NMC or GPhC check and your partner account.
03
DAY 3
Order your first kits
Starter stock dispatched the same day.
04
ONGOING
Offer and track
Patients test; you follow every sample in the portal.
RAPID CYP2C19 TESTING
Close the Clopidogrel testing gap
Around 32% of UK patients may not metabolise Clopidogrel effectively, rising to 57% in British South Asian populations.Source: NICE diagnostics guidance DG59, CYP2C19 genotype testing before Clopidogrel (2024).
FAST TURNAROUND
Results within days
Lab-based rapid CYP2C19 test for timely prescribing decisions.
BEYOND NICE CRITERIA
Patients already on Clopidogrel
Offer testing after a previous stroke, heart attack, stent or clot diagnosis.
WIDER INSIGHT
Upgrade to the full panel
Add the PGx Panel Test covering 78 medicines when it helps your patient.
ONGOING SUPPORT
Everything you need to offer PGx with confidence
You won’t be doing this alone. From your very first PGx patient, our clinical and marketing teams help you introduce PGx testing, interpret results and grow demand.
Clinical support
Our clinical team is on hand for you and your patients, from the first conversation to the report review.
Onboarding call and CPD-style clinician guide
Help interpreting any report, by phone or email, within one working day
Evidence pack for pre-authorisation, audits and appraisals
Marketing support
We help you build demand so the service pays for itself.
Patient leaflets, posters and consult-room cards, co-branded
Website, email and social copy you can reuse
A listing in the Mantara partner finder, with your clinic details
PRIVATE MEDICAL INSURANCE
Billable through private medical insurance
Both Mantara tests have their own CCSD codes, so you can bill them to your patients’ private medical insurers in the same way as other diagnostic tests.
CCSD CODES
PGx Panel Test (12 genes, 78 medicines)
3028G
Rapid Clopidogrel (CYP2C19) Test
3033G
How it works • Check the patient’s cover. The patient or your practice confirms with their insurer that the test is covered under their policy. • Get pre-authorisation. Quote the CCSD code and the clinical reason for testing (e.g. starting Clopidogrel after a stroke, or a history of side effects). • Order and bill as usual. Order through your partner account and invoice the insurer using the code.
Need help with a claim?
Our team can provide supporting evidence for pre-authorisation, including the NICE recommendation for CYP2C19 testing in stroke and TIA patients.